Format

Send to

Choose Destination
J Infect Dis. 2014 Aug 1;210(3):473-82. doi: 10.1093/infdis/jiu091. Epub 2014 Feb 12.

Increased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulin.

Author information

1
Division of Infectious Diseases and Hospital Epidemiology.
2
Division of Surgical Intensive Care Medicine, University Hospital Zurich, University of Zurich, Switzerland.

Abstract

The Gram-positive human pathogen Staphylococcus aureus causes a variety of human diseases such as skin infections, pneumonia, and endocarditis. The micrococcal nuclease Nuc1 is one of the major S. aureus virulence factors and allows the bacterium to avoid neutrophil extracellular trap (NET)-mediated killing. We found that addition of the protein synthesis inhibitor clindamycin to S. aureus LAC cultures decreased nuc1 transcription and subsequently blunted nuclease activity in a molecular beacon-based fluorescence assay. We also observed reduced NET degradation through Nuc1 inhibition translating into increased NET-mediated clearance. Similarly, pooled human immunoglobulin specifically inhibited nuclease activity in a concentration-dependent manner. Inhibition of nuclease activity by clindamycin and immunoglobulin enhanced S. aureus clearance and should be considered in the treatment of S. aureus infections.

KEYWORDS:

NET; Staphylococcus aureus; clindamycin; immunoglobulin; molecular beacon; nuclease

PMID:
24526740
PMCID:
PMC4091580
DOI:
10.1093/infdis/jiu091
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center